This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (27)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

François Aubin, MD
Department of Functional Dermatology University Hospital 25030 Besançon Cedex, France

Régis Angonin, MD; Philippe Humbert, MD; Pierre Agache, MD
Besançon, France

Arch Dermatol. 1994;130(10):1329-1330.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The association of lichen planus (LP) with liver diseases, first described in 1978 by Rebora et al,¹ has successively been confirmed by numerous observations.² However, the role played by hepatitis B virus (HBV) infection remains to be explained. We describe a man in whom LP developed after an HBV vaccination. Two analogous cases have been observed previously,^3,4 and our observation suggests that the vaccine could be involved in the pathogeny.

Report of a Case.

A 50-year-old man who was at risk forHBV infection received HBV vaccine (Gen Hevac B, Pasteur Institute, Paris, France). This is a noninfectant recombinant vaccine produced in mammalian cells, which contains the S and pre-S2 antigens involving the products of the S and pre-S2 regions of HBV DNA. The first dose of vaccine (0.5 mL) was given to our patient in June 1992 and the second (0.5 mL) 1 month later. In August, . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?